Vanderbilt University 5R01AR083437-02

Engineered cells as agents of arthritis therapy governed by artificial signaling

NIH grant awarded to Vanderbilt University for developing engineered cell therapies targeting arthritis using synthetic biology and gene regulation techniques.

Description

This is a NIH grant project for developing bioengineering cell therapies for arthritis, with a focus on synthetic biology and gene regulation in joint-resident cells. The project involves in vitro and in vivo studies, and aims to establish off-the-shelf gene therapy approaches.

View original record